CH
Christopher N Hahn
South Australia Pathology, Adelaide University, The University of Adelaide
Research areas: Medicine · Hematology · Acute Myeloid Leukemia Research · Retinoids in leukemia and cellular processes · Blood disorders and treatments
0000-0001-5105-2554
Employment
-
SA Pathology Section Head - Molecular Pathology Research Laboratory2008 - Present
-
Adelaide University Head Molecular Pathology Research2005 - 2027
Education
- 1987 - 1991
Projects & Funding
Projects & funding information is unavailable.
Publications (109)
- Supplementary Table 1 from Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment Save
- Supplementary Table 2 from Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment Save
- Supplementary Table 3 from Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment Save
- Supplementary Table 4 from Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment Save
- Supplementary Table 5 from Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment Save
- Supplementary Table 6 from Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment Save
- Supplementary Table 7 from Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment Save
- Community co-designed workshops build confidence in use of functional evidence for variant classification Save
- RBC transfusion dependency refines the Molecular International Prognostic Scoring System for myelodysplastic syndrome Save
- RAS mutation identifies a poor prognostic molecular subtype of therapy-related myeloid neoplasm. Save
- Case Report: a heterozygous loss-of-function variant of the ERG gene in a family with vascular pathologies Save
- Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations. Save
- Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort Save
- Consultation informs strategies to improve functional evidence use in variant classification Save
- Data from Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment Save
- Supplementary Table 1 from Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment Save
- Supplementary Table 2 from Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment Save
- Supplementary Table 3 from Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment Save
- Supplementary Table 4 from Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment Save
- Supplementary Table 5 from Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment Save